Autism Clinics Accused of $46 Million Medicaid Fraud Scheme

By VirentaNews Staff — May 23, 2026

In a quiet suburban strip mall in Bloomington, Minnesota, fluorescent lights hummed over the unassuming offices of what had appeared to be a dedicated autism therapy center. Children shuffled in with backpacks, parents signed in at reception desks, therapists led sessions behind frosted glass. But behind this veneer of clinical care, federal prosecutors now allege a vast fraud operation spanned years—where children who didn’t need therapy were diagnosed with autism, enrolled in expensive treatment, and used as pawns in a $46 million scheme to exploit Medicaid. The scene, replicated at another clinic in Maplewood, has unraveled into one of the most brazen cases of healthcare fraud targeting vulnerable families and public health funds in recent memory.

Fake Diagnoses and Coercive Enrollment

Federal indictments unsealed in 2024 charge two Minnesota-based applied behavior analysis (ABA) therapy providers—Behavioral Pediatrics, Inc. and its affiliated clinic, Pediatric Behavioral Services—with orchestrating a massive Medicaid fraud operation. Prosecutors allege that clinicians at the centers systematically issued autism diagnoses to children who did not meet clinical criteria, often after cursory or entirely fabricated evaluations. Once diagnosed, children were funneled into intensive, long-term ABA therapy—costing up to $120,000 per year per patient—that Medicaid was then billed for in full. Shockingly, the Justice Department claims the clinics provided cash kickbacks—sometimes $300 or more per child—to parents in exchange for enrolling their children in treatment, effectively paying families to participate in the fraud. Over several years, the clinics allegedly submitted more than $46 million in false claims to Minnesota’s Medicaid program, Medical Assistance.

The Rise of ABA and Loopholes in Oversight

The fraud case emerges from a broader context of soaring demand for autism services and expanding public funding. ABA therapy, long promoted as the gold standard for treating autism spectrum disorder, has been widely covered by Medicaid and private insurers following state and federal mandates. As diagnosis rates climbed—now affecting 1 in 36 children in the U.S. according to the CDC—the number of ABA providers ballooned, particularly in states like Minnesota with generous reimbursement policies. But rapid growth outpaced oversight. Regulatory gaps allowed private clinics to self-certify diagnoses and bill for services with minimal scrutiny. The Justice Department says the accused clinics exploited these weaknesses, using loosely trained staff to generate diagnoses and leveraging automated billing systems to maximize claims. While most ABA providers operate ethically, this case underscores how financial incentives, coupled with weak auditing, created fertile ground for abuse.

Owners, Employees, and Complicit Parents

At the center of the scheme are the clinics’ owners—two married couples who operated the businesses as family-run enterprises. According to court documents, they directed clinicians to prioritize enrollment over clinical judgment and set performance targets tied to revenue. Employees, including some licensed psychologists, are accused of rubber-stamping evaluations or altering records to meet autism criteria. Some staff later cooperated with investigators, revealing internal pressure to keep patient numbers high. Perhaps most troubling are the roles of certain parents, who prosecutors say knowingly accepted cash in exchange for allowing their children to be falsely diagnosed. While not all parents are accused of wrongdoing—many believed their children needed help—the use of financial incentives blurred ethical lines and turned caregiving into a transaction. The indictment names seven individuals, including clinic directors, clinical supervisors, and recruiters.

Impact on Families and Public Trust

The fallout extends far beyond the courtroom. For families whose children were wrongly labeled with autism, the consequences include emotional trauma, stigmatization, and unnecessary medicalization of normal developmental variation. Some children were pulled from school for therapy they didn’t need, losing critical social and academic time. For families who genuinely rely on ABA services, the scandal threatens access: regulators may tighten eligibility rules or delay reimbursements in response. Medicaid programs, already strained, face renewed scrutiny over fraud prevention. Minnesota’s Department of Human Services has launched an internal review, while advocacy groups like Autism Speaks have called for stronger accreditation standards. The case also risks deepening skepticism about autism diagnoses, potentially discouraging early intervention for children who truly need it.

The Bigger Picture

This case is not just about fraud—it’s about the collision of well-intentioned policy, profit motives, and inadequate oversight. As public programs expand to support neurodiverse populations, they become targets for exploitation. Similar ABA fraud cases have surfaced in Texas and California, suggesting a national vulnerability. The Department of Justice has made healthcare fraud a priority, recovering over $2.6 billion in false claims last year alone. But prevention requires more than prosecution. It demands independent diagnostic verification, real-time billing audits, and ethical safeguards embedded in care delivery. Without them, the very systems designed to help the most vulnerable may be turned against them.

As the legal proceedings unfold, federal authorities are likely to pursue prison sentences and full restitution. But the broader reckoning is just beginning. Rebuilding trust in autism services will require transparency, stricter licensing, and a renewed focus on patient welfare over revenue. For the families caught in the crossfire—those misdiagnosed, those who lost access, and those who still need help—the path forward must be guided not by profit, but by science and compassion.

Source: The New York Times